Monitoring
Every trade rule change Olive tracks for importers and exporters, from CBP, Commerce, Treasury, USTR, the Federal Register and regulators abroad, each with its official source.
USTR is making a conforming amendment to a Section 301 China product exclusion to reflect HTSUS statistical reporting changes effective July 1, 2026.
24 changes
CBP's ACE system will undergo standard invasive maintenance from 10:00 p.m. ET Saturday, October 10, 2026, to 4:00 a.m. ET Sunday, October 11, 2026.
CBP's ACE system will undergo standard invasive maintenance from 5:00 a.m. to 7:00 a.m. ET on Thursday, October 08, 2026, possibly delaying response notifications.
CBP reminds that a Post-Deployment Support Call on the new Entry Type 13 test in ACE for U.S. mail processing (INT-057, CBP-290) is held today, October 7, 2026.
FDA corrects its September 13, 2023 notice to add that ANDAs referencing Oxandrin (oxandrolone) tablets, 2.5 mg and 10 mg, were also withdrawn for safety or effectiveness reasons.
USTR says the Section 301 tariffs on Chinese goods from its 2018 technology transfer investigation did not end and remain in effect, after domestic industries asked for them to continue. They may still be modified as the four-year review goes on.
CBP's ACE certification environment will undergo a standard invasive maintenance window on October 7, 2026, from 5:00 p.m. to 8:00 p.m. ET.
CBP Quota Bulletin 26-310 reports the 2027 specialty sugar tariff rate quota under HTSUS Chapter 17 and 21, AUSN 5, opened October 1, 2026 and was oversubscribed, with a pro rata of 44.58212%.
CBP Quota Bulletin 26-319 reports that the 2027 refined sugar tariff rate quota under HTSUS Chapter 17 and 21, AUSN 5, opened October 1, 2026 oversubscribed, with entries prorated at 51.03027%.
Commerce issues a correction to the final results of the first and second sunset reviews of the countervailing duty order on drawn stainless steel sinks from China, fixing an incorrectly stated all-others rate of 8.61 percent.
A corrigendum corrects Commission Implementing Decision (EU) 2026/1205 of 9 June 2026, which amends Decision 2006/199/EC setting specific conditions for imports of fishery products from the United States of America.
This notice corrects an error in Council Decision (EU) 2026/1099 of 27 April 2026 on the EU's conclusion of the Beijing Convention on the Judicial Sale of Ships.
FDA is opening a public docket for comments on its proposed design and safety approaches for early-phase clinical trials of ibogaine drug products, including HHS-funded studies in OUD and PTSD.
FDA determined that Pralidoxime Chloride (Autoinjector) solution, 600 mg/2 mL (300 mg/mL), was not withdrawn for safety or effectiveness reasons, allowing approval of ANDAs for this drug if other requirements are met.
FDA announces issuance of a priority review voucher to the sponsor of the approved rare pediatric disease product FAYUVI (rebisufligene etisparvovec-hopf).
FDA classifies the hyperoxia monitoring device adjunct to pulse oximetry as a class II medical device subject to identified special controls.
FDA has finalized an order exempting certain class II clinical toxicology test systems from premarket notification (510(k)) requirements, subject to stated limitations, effective immediately.
FDA classifies the focused ultrasound system for non-thermal, mechanical tissue ablation into class II, subject to identified special controls.
FDA is classifying the high throughput DNA sequencing for hereditary cancer predisposition assessment test system into class II, subject to special controls.
FDA issues a correction to its May 7, 2026 notice withdrawing approval of 15 ANDAs effective June 8, 2026, including corrections to ANDA 210285 for dimethyl fumarate delayed-release capsules.
Commerce's final results of the expedited second sunset review determine that revoking the antidumping duty order on melamine from China would likely lead to continued or recurring dumping.
CPSC is inviting oral comments on its proposed safety standard for lithium-ion batteries used in micromobility products and their electrical systems.
OFAC has removed and updated certain sanctions designations and published a new Iran-related alert along with an amended Iran-related FAQ.
USTR is requesting public comments and holding a public hearing on the operation of the USMCA ahead of the 2027 annual joint review meeting.
Sources
The official sites behind the changes above, grouped by the same topics, and the professional organizations trade teams keep close: 37 in all, for importers and exporters. Every link goes to the organization's own site.
Section 232 and 301 actions, IEEPA duties, tariff proclamations and revisions of the tariff schedule.
Antidumping and countervailing duty orders, reviews and investigations.
Consumer product, food and drug rules a product must meet to be sold.
The EAR and the ITAR, licences, the Entity List and export filing.
Sanctions programs, designations and the lists every party is screened against.
How goods are entered and cleared: CBP messages, ACE, rulings and filing rules.
USMCA and other agreements, preference programs and trade negotiations.
What Canada, Mexico and the EU require of goods arriving from the US.
The journal where US agencies publish rules and notices, and the codified regulations they amend.
Associations for customs brokers, importers, exporters and compliance professionals: training, credentials and peers.
Olive reads every change like these against your own products, codes and trade lanes, whether you import, export or both, and drafts the update to your compliance program for your approval. Nothing changes without you.
Olivra lists official notices for information only. It is not legal advice, and Olive is not a lawyer or a licensed customs broker. The official text at the source is what counts.